Bupropion Hydrochloride 150 mg
1 INDICATIONS AND USAGE Bupropion hydrochloride extended-release (SR) tablets are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM). The efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with MDD [see Clinical Studies (14) ] . The efficacy of bupropion hydrochloride extended-release (SR) tablets in maintaining an antidepressant response for up to 44 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial [see Clinical Studies (14) ] . Bupropion hydrochloride extended-release (SR) tablets are an aminoketone antidepressant, indicated for the treatment of major depressive disorder (MDD). ( 1 )
Solco Healthcare US LLC
ROUND PURPLE S 525
S 525 ROUND PURPLE
Related Pills
bupropion 200 mg
Solco Healthcare US LLC
Bupropion Hydrochloride 150 mg
Solco Healthcare US LLC
Bupropion Hydrochloride 100 mg
Solco Healthcare US LLC
Bupropion Hydrochloride 100 mg
Solco Healthcare US LLC
Bupropion Hydrochloride 150 mg
Solco Healthcare US LLC
bupropion 200 mg
solco healthcare us llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
BUPROPION HYDROCHLORIDE extended-release tablets USP (SR), 100 mg of
BUPROPION HYDROCHLORIDE, USP are blue, round, biconvex, film-coated tablets debossed with “S” on one side and “522” on the other. Bottles of 60 NDC # 43547-288-06 Bottles of 90 NDC # 43547-288-09 Bottles of 100 NDC # 43547-288-10 Bottles of 500 NDC # 43547-288-50
BUPROPION HYDROCHLORIDE, USP extended-release tablets USP (SR), 150 mg of
BUPROPION HYDROCHLORIDE, USP are purple, round, biconvex, film-coated tablets debossed with “S” on one side and “525” on the other. Bottles of 60 NDC # 43547-289-06 Bottles of 90 NDC # 43547-289-09 Bottles of 100 NDC # 43547-289-10 Bottles of 250 NDC # 43547-289-25 Bottles of 500 NDC # 43547-289-50
BUPROPION HYDROCHLORIDE extended-release tablets USP (SR), 200 mg of
BUPROPION HYDROCHLORIDE, USP are pink, round, biconvex, film-coated tablets debossed with “S” on one side and “527” on the other. Bottles of 60 NDC # 43547-290-06 Bottles of 90 NDC # 43547-290-09 Bottles of 100 NDC # 43547-290-10 Bottles of 500 NDC # 43547-290-50 Store at room temperature, 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Protect from light and moisture.
More pills like ROUND S 525